Figure 2From: The anti-myeloma activity of a novel purine scaffold HSP90 inhibitor PU-H71 is via inhibition of both HSP90A and HSP90B1Effect of PU-H71 on cell cycle. (A) DNA content analysis by flow cytometry performed on MM.1R and RPMI-8226/DOX40 cells exposed to PU-H71 (100 nM) for 24 hours. (B) Intracellular staining for cyclin D1 in MM.1R cells after 24-hour treatment with PU-H71 (100 nM).Back to article page